Small vessel vasculitis History, classification, etiology, histopathology, clinic, diagnosis and treatment
暂无分享,去创建一个
[1] D A Bloch,et al. The American College of Rheumatology 1990 criteria for the classification of vasculitis. Introduction. , 2010, Arthritis and rheumatism.
[2] R. Falk,et al. Nosology of primary vasculitis , 2007, Current opinion in rheumatology.
[3] U. Maggiore,et al. Outcome and prognostic factors during the course of primary small-vessel vasculitides. , 2006, The Journal of rheumatology.
[4] R. Luqmani,et al. Outcome in small-vessel systemic vasculitis. , 2006, The Journal of rheumatology.
[5] A. I. Gamarra,et al. Hitos históricos de las vasculitis de pequeños vasos , 2006 .
[6] P. Chapman,et al. The epidemiology of Wegener's granulomatosis and microscopic polyangiitis in a Southern Hemisphere region. , 2006, Rheumatology.
[7] R. Luqmani,et al. Clinical and biological assessment in systemic necrotizing vasculitides. , 2006, Clinical and experimental rheumatology.
[8] A. I. Gamarra,et al. Análisis crítico de las clasificaciones de las vasculitis , 2006 .
[9] C. Langford,et al. Advances in the treatment of small vessel vasculitis. , 2006, Rheumatic diseases clinics of North America.
[10] C. Stegeman. Predictive value of antineutrophil cytoplasmic antibodies in small-vessel vasculitis: is the glass half full or half empty? , 2005, The Journal of rheumatology.
[11] G. Hoffman,et al. Are There Different Forms of Life in the Antineutrophil Cytoplasmic Antibody Universe? , 2005, Annals of Internal Medicine.
[12] Ying Zhang,et al. Characteristics of Chinese patients with Wegener's granulomatosis with anti-myeloperoxidase autoantibodies. , 2005, Kidney international.
[13] F. Spertini,et al. Predictive value of antineutrophil cytoplasmic antibodies in small-vessel vasculitis. , 2005, The Journal of rheumatology.
[14] Jianwen Cai,et al. Predictors of Relapse and Treatment Resistance in Antineutrophil Cytoplasmic AntibodyAssociated Small-Vessel Vasculitis , 2005, Annals of Internal Medicine.
[15] C. Kallenberg. Churg-Strauss syndrome: just one disease entity? , 2005, Arthritis and rheumatism.
[16] Laura Pavone,et al. Prevalence and clinical significance of antineutrophil cytoplasmic antibodies in Churg-Strauss syndrome. , 2005, Arthritis and rheumatism.
[17] David G I Scott,et al. Epidemiology of systemic vasculitis , 2005, Current rheumatology reports.
[18] J. Stone,et al. Randomized controlled trials in vasculitis associated with anti-neutrophil cytoplasmic antibodies , 2005, Current opinion in rheumatology.
[19] J. Savige,et al. What do antineutrophil cytoplasmic antibodies (ANCA) tell us? , 2005, Best practice & research. Clinical rheumatology.
[20] J. Stone,et al. The antineutrophil cytoplasmic antibody-associated vasculitides. , 2004, The American journal of medicine.
[21] I. Uthman. Pharmacological therapy of vasculitis: an update. , 2004, Current opinion in pharmacology.
[22] E. Popa,et al. Staphylococcal superantigens and T cell expansions in Wegener's granulomatosis , 2003, Clinical and experimental immunology.
[23] E. Csernok. Anti-neutrophil cytoplasmic antibodies and pathogenesis of small vessel vasculitides. , 2003, Autoimmunity reviews.
[24] J. Balow,et al. New insights into the immunopathogenesis and treatment of small vessel vasculitis of the kidney , 2003, Current opinion in nephrology and hypertension.
[25] L. Guillevin,et al. When should immunosuppressants be prescribed to treat systemic vasculitides? , 2003, Internal medicine.
[26] C. Magro,et al. Cutaneous vasculitis: a review , 2003, Journal of cutaneous pathology.
[27] L. Kamesh,et al. ANCA-positive vasculitis. , 2002, Journal of the American Society of Nephrology : JASN.
[28] P. Leboit,et al. Vasculitis: The true and the near-true. , 2002, The American Journal of dermatopathology.
[29] E. Thervet,et al. Henoch-Schönlein Purpura in adults: outcome and prognostic factors. , 2002, Journal of the American Society of Nephrology : JASN.
[30] C. Kallenberg,et al. New insights into the pathogenesis of antineutrophil cytoplasmic autoantibody-associated vasculitis. , 2002, Autoimmunity reviews.
[31] E. Matteson. Historical perspective of vasculitis: Polyarteritis nodosa and microscopic polyangiitis , 2002, Current rheumatology reports.
[32] M. González-Gay,et al. Epidemiology of the vasculitides. , 2001, Rheumatic diseases clinics of North America.
[33] J. Llorca,et al. Henoch-Schönlein Purpura in Children from Northwestern Spain: A 20-Year Epidemiologic and Clinical Study , 2001, Medicine.
[34] J. Levy. New aspects in the management of ANCA-positive vasculitis. , 2001, Nephrology, dialysis, transplantation : official publication of the European Dialysis and Transplant Association - European Renal Association.
[35] E. Matteson. Notes on the history of eponymic idiopathic vasculitis: the diseases of Henoch and Schönlein, Wegener, Churg and Strauss, Horton, Takayasu, Behçet, and Kawasaki. , 2000, Arthritis care and research : the official journal of the Arthritis Health Professions Association.
[36] R. Gans,et al. Antiproteinase 3- and antimyeloperoxidase-associated vasculitis. , 2000, Kidney international.
[37] R. Kettritz,et al. Necrotizing small-vessel vasculitis confined to the uterine cervix. , 2000, Seminars in arthritis and rheumatism.
[38] Lawrence E. Gibson,et al. Erythema elevatum diutinum. , 2000, Clinics in dermatology.
[39] C. Ferreli,et al. Less common treatment in cutaneous vasculitis. , 1999, Clinics in dermatology.
[40] N. Cassano,et al. Immunosuppressive therapy in cutaneous vasculitis. , 1999, Clinics in dermatology.
[41] G. Hautmann,et al. The many faces of cutaneous vasculitis. , 1999, Clinics in dermatology.
[42] L. Parish,et al. Vasculitis: the historical development of the concept , 1999 .
[43] T. Lotti,et al. Proposal for a working classification of cutaneous vasculitis. , 1999, Clinics in dermatology.
[44] C. Kallenberg,et al. What is new with anti-neutrophil cytoplasmic antibodies: diagnostic, pathogenetic and therapeutic implications. , 1999, Current opinion in nephrology and hypertension.
[45] E. Hachulla,et al. Serial measurements of antineutrophil cytoplasmic autoantibodies in patients with systemic vasculitis. , 1999, The American journal of medicine.
[46] C. Franssen,et al. Disease spectrum of patients with antineutrophil cytoplasmic autoantibodies of defined specificity: distinct differences between patients with anti‐proteinase 3 and anti‐myeloperoxidase autoantibodies , 1998, Journal of internal medicine.
[47] P Lesavre,et al. Diagnostic value of standardized assays for anti-neutrophil cytoplasmic antibodies in idiopathic systemic vasculitis. EC/BCR Project for ANCA Assay Standardization. , 1998, Kidney international.
[48] R. Falk,et al. Small-vessel vasculitis. , 1997, The New England journal of medicine.
[49] V. Rodríguez-Valverde,et al. Clinical features and outcome of 95 patients with hypersensitivity vasculitis. , 1997, The American journal of medicine.
[50] D. Fiorentino,et al. Cutaneous vasculitis , 1996 .
[51] T. Lotti,et al. CUTANEOUS NECROTIZING VASCULITIS , 1996, International journal of dermatology.
[52] E. R. Mcfadden,et al. Hypocomplementemic Urticarial Vasculitis Syndrome: Clinical and Serologic Findings in 18 Patients , 1995, Medicine.
[53] C. Kallenberg,et al. Anti-neutrophil cytoplasmic antibodies: current diagnostic and pathophysiological potential. , 1994, Kidney international.
[54] R J Falk,et al. Nomenclature of systemic vasculitides. Proposal of an international consensus conference. , 1994, Arthritis and rheumatism.
[55] J. Callen. Cutaneous vasculitis: Relationship to systemic disease and therapy , 1993 .
[56] E. Egea,et al. Análisis histórico de las Vasculitis, su clasificación y propuesta para su entendimiento , 1993 .
[57] E. Csernok,et al. ANCA and associated diseases: immunodiagnostic and pathogenetic aspects , 1993, Clinical and experimental immunology.
[58] D. Mehregan,et al. Urticarial vasculitis: a histopathologic and clinical review of 72 cases. , 1992, Journal of the American Academy of Dermatology.
[59] T. Carey,et al. Clinical course of anti-neutrophil cytoplasmic autoantibody-associated glomerulonephritis and systemic vasculitis. The Glomerular Disease Collaborative Network. , 1990, Annals of internal medicine.
[60] T. The,et al. Prevention of relapses in Wegener's granulomatosis by treatment based on antineutrophil cytoplasmic antibody titre , 1990, The Lancet.
[61] J. Hoidal,et al. Specificity of anti-neutrophil cytoplasmic autoantibodies for proteinase 3. , 1990, Blood.
[62] P. Tugwell,et al. The American College of Rheumatology 1990 Criteria for the Classification of Fibromyalgia. Report of the Multicenter Criteria Committee. , 1990, Arthritis and rheumatism.
[63] J. Lüdemann,et al. Anti-neutrophil cytoplasm antibodies in Wegener's granulomatosis recognize an elastinolytic enzyme , 1990, The Journal of experimental medicine.
[64] C. Hack,et al. Wegener's granulomatosis autoantibodies identify a novel diisopropylfluorophosphate-binding protein in the lysosomes of normal human neutrophils. , 1989, The Journal of clinical investigation.
[65] C. Kallenberg,et al. Association between active Wegener's granulomatosis and anticytoplasmic antibodies. , 1989, Archives of internal medicine.
[66] M. Arnaout,et al. Wegener9s granulomatosis autoantigen is a novel neutrophil serine proteinase [see comments] , 1989 .
[67] M. Arnaout,et al. Wegener's granulomatosis autoantigen is a novel neutrophil serine proteinase. , 1989, Blood.
[68] J. Jorizzo,et al. Neutrophilic vascular reactions. , 1988, Journal of the American Academy of Dermatology.
[69] R. Falk,et al. Anti-neutrophil cytoplasmic autoantibodies with specificity for myeloperoxidase in patients with systemic vasculitis and idiopathic necrotizing and crescentic glomerulonephritis. , 1988, The New England journal of medicine.
[70] J. Callen. CUTANEOUS VASCULITIS AND ITS RELATIONSHIP TO SYSTEMIC DISEASE , 1987, Disease-a-month : DM.
[71] K. Weismann,et al. Erythema elevatum diutinum and pre-AIDS. , 1986, Acta dermato-venereologica.
[72] E. Alexander,et al. Two histopathologic types of inflammatory vascular disease in MRL/Mp autoimmune mice. Model for human vasculitis in connective tissue disease. , 1985, Arthritis and rheumatism.
[73] T. H. The,et al. AUTOANTIBODIES AGAINST NEUTROPHILS AND MONOCYTES: TOOL FOR DIAGNOSIS AND MARKER OF DISEASE ACTIVITY IN WEGENER'S GRANULOMATOSIS , 1985, The Lancet.
[74] W. Adam,et al. Vasculitis and glomerulonephritis: a subgroup with an antineutrophil cytoplasmic antibody. , 1984, Australian and New Zealand journal of medicine.
[75] J. Callen,et al. Cutaneous Leukocytoclastic Vasculitis: Clinical and Laboratory Features of 82 Patients Seen in Private Practice , 1984 .
[76] W. Su,et al. Lymphocytic vasculitis: is it a specific clinicopathologic entity? , 1984, Journal of cutaneous pathology.
[77] J. Elias,et al. Histologic studies of chronic idiopathic urticaria. , 1983, The Journal of allergy and clinical immunology.
[78] J. E. Moran,et al. Segmental necrotising glomerulonephritis with antineutrophil antibody: possible arbovirus aetiology? , 1982, British medical journal.
[79] F. C. Mcduffie,et al. Hypocomplementemic urticarial vasculitis: association with chronic obstructive pulmonary disease. , 1982, Mayo Clinic proceedings.
[80] F. Mullick,et al. Drug related vasculitis. Clinicopathologic correlations in 30 patients. , 1979, Human pathology.
[81] Soter Na,et al. Cutaneous necrotizing venulitis. , 1979 .
[82] B. Haynes,et al. The spectrum of vasculitis: clinical, pathologic, immunologic and therapeutic considerations. , 1978, Annals of internal medicine.
[83] J. Callen,et al. CUTANEOUS ANGIITIS (VASCULITIS) , 1978, International journal of dermatology.
[84] A. Fauci,et al. ERYTHEMA ELEVATUM DIUTINUM: SKIN AND SYSTEMIC MANIFESTATIONS, IMMUNOLOGIC STUDIES, AND SUCCESSFUL TREATMENT WITH DAPSONE , 1977, Medicine.
[85] Smiley Jd,et al. Cutaneous necrotizing vasculitis and related disorders. , 1976 .
[86] M. Mihm,et al. Two distinct cellular patterns in cutaneous necrotizing angiitis. , 1976, The Journal of investigative dermatology.
[87] T. Ryan,et al. THE PROBLEMS OF CLASSIFICATION OF CUTANEOUS ANGIITIS WITH REFERENCE TO HISTOPATHOLOGY AND PATHOGENESIS , 1970 .
[88] J. Churg,et al. Wegener's granulomatosis: pathology and review of the literature. , 1954, A.M.A. archives of pathology.
[89] P. Zeek. Periarteritis nodosa and other forms of necrotizing angiitis. , 1953, The New England journal of medicine.
[90] P. Zeek. Periarteritis Nodosa: A Critical Review , 1952 .
[91] J. Churg,et al. Allergic granulomatosis, allergic angiitis, and periarteritis nodosa. , 1951, The American journal of pathology.
[92] Gouley. Studies on periarteritis nodosa. III. The differentiation between the vascular lesions of periarteritis nodosa and of hypersensitivity , 1949 .
[93] R PLATT,et al. The kidney in periarteritis nodosa. , 1948, The Quarterly journal of medicine.
[94] P. Zeek,et al. Studies on periarteritis nodosa; the differentiation between the vascular lesions of periarteritis nodosa and of hypersensitivity. , 1948, The American journal of pathology.
[95] F. Weidman,et al. ERYTHEMA ELEVATUM DIUTINUM: ROLE OF STREPTOCOCCI, AND RELATIONSHIP TO OTHER RHEUMATIC DERMATOSES , 1929 .
[96] Privatdozent Dr. Friedrich Wohlwill. Über die nur mikroskopisch erkennbare Form der Periarteriitis nodosa , 1923, Virchows Archiv für pathologische Anatomie und Physiologie und für klinische Medizin.
[97] W. Osler. THE VISCERAL LESIONS OF PURPURA AND ALLIED CONDITIONS , 1914, British medical journal.
[98] R. Willan. On Cutaneous Diseases , 1845 .
[99] M. Rodríguez,et al. Vasculitis de vasos de pequeño calibre con afectación renopulmonar , 2009 .
[100] M. López-Rodríguez,et al. [Historical perspective on the classification of vasculitis]. , 2007, Actas dermo-sifiliograficas.
[101] S. Hodes,et al. Cutaneous Leukocytoclastic Vasculitis in a Patient with HIV , 2007 .
[102] J. Brewer,et al. HYPOCOMPLEMENTEMIC URTICARIAL VASCULITIS SYNDROME , 2006 .
[103] L. Moreland. Cutaneous leukocytoclastic vasculitis , 2004 .
[104] W. Koldingsnes,et al. Baseline features and initial treatment as predictors of remission and relapse in Wegener's granulomatosis. , 2003, The Journal of rheumatology.
[105] A. Iglesias,et al. Historia de las vasculitis , 2002 .
[106] P. Merkel,et al. Subacute bacterial endocarditis with positive cytoplasmic antineutrophil cytoplasmic antibodies and anti-proteinase 3 antibodies. , 2000, Arthritis and rheumatism.
[107] J. J. Wisnieski. Urticarial vasculitis. , 2000, Current opinion in rheumatology.
[108] W. Gross. [Primary systemic vasculitis. I. General overview]. , 1999, Der Internist.
[109] G. Hoffman,et al. Antineutrophil cytoplasmic antibodies. , 1998, Arthritis and rheumatism.
[110] R. Falk,et al. Prognostic markers in patients with antineutrophil cytoplasmic autoantibody-associated microscopic polyangiitis and glomerulonephritis. , 1996, Journal of the American Society of Nephrology : JASN.
[111] C. Kallenberg,et al. Association of Chronic Nasal Carriage of Staphylococcus aureus and Higher Relapse Rates in Wegener Granulomatosis , 1994, Annals of Internal Medicine.
[112] W. Piette. The differential diagnosis of purpura from a morphologic perspective. , 1994, Advances in dermatology.
[113] J. Jorizzo. Classification of vasculitis. , 1993, The Journal of investigative dermatology.
[114] C J Michet,et al. Epidemiology of vasculitis. , 1990, Rheumatic diseases clinics of North America.
[115] J. Callen,et al. Cutaneous leukocytoclastic vasculitis. Serial histopathologic evaluation demonstrates the dynamic nature of the infiltrate. , 1990, Archives of dermatology.
[116] Lie Jt. Systemic and isolated vasculitis. A rational approach to classification and pathologic diagnosis. , 1989 .
[117] E. Egea,et al. Vasculitis linfomonocitica. Informe de nueve casos , 1987 .
[118] J. Melski,et al. Cutaneous necrotizing venulitis. , 1979, Cutis.
[119] W. M. Sams,et al. Hypocomplementemia with cutaneous vasculitis and arthritis: a new syndrome. , 1974, Archives of dermatology.
[120] F. Wegener. Über eine eigenartige rhinogene Granulomatose mit besonderer Beteiligung des Arterien systems und der Nieren , 1939 .